Aligos Therapeutics (ALGS)

• Market cap: $60.8M
• 1 day: 2.38%
• 5 days: 6.01%
• 1 month: -8.35%
• 3 months: -0.5%
• 6 months: 19.9%
• Year to date: 8.21%
• 1 year: -74.26%
• 5 years: -98.75%
• 10 years: -97.34%
• Sector: Healthcare
• Industry: Biotechnology

About: Aligos Therapeutics Inc is a clinical stage biopharmaceutical company. It is engaged in developing novel therapeutics to address unmet medical needs in viral and liver diseases, including chronic hepatitis B and coronaviruses, and therapeutics for nonalcoholic steatohepatitis (NASH). The company's pipeline includes ALG-010133, ALG-000184, ALG-020572 and ALG-055009, among others.

Employees: 70